Pharmacological inhibition and genetic deficiency of SCD1 was further found to reduce autoimmune-mediated demyelination in the experimental autoimmune encephalomyelitis (EAE) model, a well described animal model for MS that mimics autoimmune-mediated degenerative events in the CNS [47]. This evidence concerns the gene SCD and myeloid sarcoma.